Transparency for global health aid: 60% of disease burden draws just 2.5% of targeted funds, analysis reveals
To what extent does the allocation of aid for combating disease correspond to disease burden? LMU researchers have developed a machine-learning pipeline that helps uncover relative discrepancies in aid distribution.
A recent analysis led by researchers at LMU has uncovered significant imbalances in the allocation of global health aid funds in comparison to the disease burden they are meant to combat. Using a machine-learning pipeline, the team examined 320,000 disease-related aid projects spanning from 2000 to 2022 and totaling $332 billion in funding.
The study found that while noncommunicable diseases, such as cardiovascular conditions, diabetes, and kidney diseases, represent around 60% of the global disease burden, they only received 2.5% of the targeted aid funding. Conversely, diseases like HIV and other sexually transmitted infections, which only account for 6% of the global disease burden, received 34% of the aid.
This imbalance is particularly concerning as the burden from noncommunicable diseases continues to rise, even in low- and middle-income countries. The researchers emphasize that their findings, published in Nature Communications, provide transparency and a basis for political decisions in global health aid distribution, potentially guiding resources to where they are most urgently needed.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
